Effect of interferon on severe psychiatric diseases
Cantell, K.; Pulkkinen, E.; Elosuo, R.; Suominen, J.
Annals of Clinical Research 12(3): 131-132
1980
ISSN/ISBN: 0003-4762 PMID: 6160802 Document Number: 155188
Document emailed within 1 workday
Related Documents
Linkesch, W.; Gisslinger, H.; Ludwig, H.; Flener, R.; Sinzinger, H. 1985: Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses Acta Medica Austriaca 12(5): 123-127Chernushenko, E.F.; Belianovskaia, T.I.; Kuznetsova, L.V.; Shpak, O.I.; Shatrov, V.A. 1986: Effect of leukocytic interferon on the functional state of bronchoalveolar phagocytes in lung diseases Terapevticheskii Arkhiv 58(4): 83-85
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Testa, A.; Giannuzzi, R.; Daini, S.; Bernardini, L.; Petrongolo, L.; Gentiloni Silveri, N. 2013: Psychiatric emergencies (part III): psychiatric symptoms resulting from organic diseases European Review for Medical and Pharmacological Sciences 17(Suppl 1): 86-99
Lvovsky, E.A.; D'Souza, J.; Eng, D.; D'Souza, D.; Lvovsky, B.; Hetland, R.; Craver, W.L.; Sobel, S.H. 1988: Tumor response to interferon inducer and radiation effect of serum interferon levels Journal of Biological Regulators and Homeostatic Agents 2(1): 1-6
Fleischmann, W.R.; Kleyn, K.M.; Baron, S. 1980: Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations Journal of the National Cancer Institute 65(5): 963-966
Grigorian, S.S.; Pritsker, A.D.; Onufrieva, E.K.; Chireshkin, D.G.; Ershov, F.I. 1991: The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis Voprosy Virusologii 36(5): 407-409
Uno, N.; Nosaka, T.; Uchiyama, S.; Kawakami, K.; Hoshino, K.; Mori, M.; Hotta, Y.; Ohta, C.; Kobayashi, T.; Kita, K. 1987: Combined clinical effect of amikacin and cefoxitin in patients with severe infections complicated by hematological diseases Japanese Journal of Antibiotics 40(3): 469-475
Franke, M.; Klemm, P. 1981: Correlations between geronto psychiatric diseases and diseases of internal organs Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie 125(1): 88
Van Damme, J.; De Ley, M.; Van Snick, J.; Dinarello, C.A.; Billiau, A. 1987: The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor Journal of Immunology 139(6): 1867-1872
Bernardo, M.; Parellada, E. 1994: Mefloquine and severe psychiatric disorder Medicina Clinica 102(15): 596
Alkan, M.L.; Hermesh, H.; Atzmon, B.; Peri, G.; Schwartz, E. 1999: Severe psychiatric disorders during trips to the Far East Harefuah 136(12): 940
Fujisaki, T.; Nagafuchi, S.; Okamura, T. 1993: Gamma-interferon for severe chronic active Epstein-Barr virus Annals of Internal Medicine 118(6): 474-475
Simpson, R.B.; Nedzelski, J.M.; Barber, H.O.; Thomas, M.R. 1988: Psychiatric diagnoses in patients with psychogenic dizziness or severe tinnitus Journal of Otolaryngology 17(6): 325-330
Friedman, E.H. 1993: Severe psychiatric disease and acute colitis. On the article from D. Labayle et al Gastroenterologie Clinique et Biologique 17(3): 232
Kvitashvili, M.A.; Kuznetsov, V.P.; Pokrovskiĭ, V.I. 1982: Treatment of severe forms of viral hepatitis with injections of human leukocytic interferon Terapevticheskii Arkhiv 54(9): 28-32
Piqueras, B.; Salcedo, M.; Bañares, R.; García-Durán, F.; Baños, E.; de Diego, A.; Roldán, P.; Cos, E.; Clemente, G. 1997: Famciclovir plus interferon in the treatment of a patient with chronic hepatitis B and severe liver failure Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 89(3): 217-221
Homma, Y.; Kawazoe, K.; Ito, T.; Ide, H.; Takahashi, H.; Ueno, F.; Matsuzaki, S. 2000: Chronic hepatitis C beta-interferon-induced severe hypertriglyceridaemia with apolipoprotein e phenotype E3/2 International Journal of Clinical Practice 54(4): 212-216
González de Dios, J.; Moya Benavent, M.; Herranz Sánchez, Y.; Juste Ruiz, M.; González Montero, R. 1996: The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset Anales Espanoles de Pediatria 44(2): 179-183
Kita, M. 1994: Interferon and diseases Rinsho Byori. Japanese Journal of Clinical Pathology 42(8): 860-866